Emerging Infectious Diseases (Feb 2023)

Infant Botulism, Israel, 2007–2021

  • Bar Goldberg,
  • Dana Danino,
  • Yoel Levinsky,
  • Itzhak Levy,
  • Rachel Straussberg,
  • Halima Dabaja-Younis,
  • Alex Guri,
  • Yotam Almagor,
  • Diana Tasher,
  • Daniel Elad,
  • Zina Baider,
  • Shlomo Blum,
  • Oded Scheuerman

DOI
https://doi.org/10.3201/eid2902.220991
Journal volume & issue
Vol. 29, no. 2
pp. 235 – 241

Abstract

Read online

Infant botulism (IB) is an intestinal toxemia that manifests as descending paralysis, constipation, and, in some cases, respiratory failure. Laboratory-confirmed IB cases are rare, and recent data in Israel are lacking. We conducted a national multicenter retrospective study of laboratory-confirmed IB cases reported in Israel during 2007–2021. A total of 8 cases were reported during the study period. During 2019–2021, incidence may have increased because of a cluster of 5 cases. Infant median age for diagnosis was 6.5 months, older than previously reported (3 months). Most cases occurred during March–July. Honey consumption was reported in 1 case, and possible environmental risk factors (living nearby rural or construction areas, dust exposure, and having a father who works as a farmer) were reported in 6 cases. Although IB is rare, its incidence in Israel may have increased over recent years, and its epidemiology and risk factors differ from cases reported previously in Israel.

Keywords